Decreased levels of platelet-derived soluble glycoprotein VI detected prior to the first diagnosis of coronary artery disease in HIV-positive individuals
HIV-positive patients are at increased risk for coronary artery disease (CAD); changes in platelet activation may play a role. This study was performed to determine if levels of soluble glycoprotein VI (sGPVI), a platelet-specific marker of activation, were different in HIV-positive patients compare...
Main Authors: | J. M. Trevillyan, E. E. Gardiner, R. K. Andrews, A. Maisa, A. C. Hearps, M. Al-Tamimi, S. M. Crowe, J. F. Hoy |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-04-01
|
Series: | Platelets |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09537104.2016.1237627 |
Similar Items
-
<i>Sinomenium acutum</i> Modulates Platelet Aggregation and Thrombus Formation by Regulating the Glycoprotein VI-Mediated Signalosome in Mice
by: Yeon-Ji Kim, et al.
Published: (2023-12-01) -
Platelet glycoprotein VI genetic quantitative and qualitative defects
by: Martine Jandrot-Perrus, et al.
Published: (2019-08-01) -
Increased platelet reactivity as measured by plasma glycoprotein VI in gout
by: Richard Conway, et al.
Published: (2018-11-01) -
Restrained glycoprotein VI-induced platelet signaling by tyrosine protein phosphatases independent of phospholipase Cγ2
by: Jingnan Huang, et al.
Published: (2023-10-01) -
Association between endometriosis, infertility and autoimmune antiplatelet glycoprotein VI antibodies in two patients
by: Stéphane Loyau, et al.
Published: (2023-12-01)